Shanghai Bio-Heart Biological Technology Co., Ltd. Class H (HK:2185)

:2185

2185

Shanghai Bio-Heart Biological Technology Co., Ltd. Class H

RESEARCH TOOLSreports

Want to see HK:2185 full AI Analyst Report?

Compare Shanghai Bio-Heart Biological Technology Co., Ltd. Class H (2185) vs. Competitors

0 Followers

Comparison Results

2185

Shanghai Bio-Heart Biological Technology Co., Ltd. Class H

HK$5.71

HK$898.21M

-18.55

45.85%

―

Genor Biopharma Holdings Limited

HK$3.06

HK$4.24B

11.60

-21.27%

―

TOT BIOPHARM International Co. Ltd.

HK$2.50

HK$3.45B

-3.90

143.85%

―

Zhaoke Ophthalmology Ltd.

HK$3.17

HK$1.39B

-4.01

8.58%

―

Immunotech Biopharm Ltd

HK$2.68

HK$487.83M

-3.95

-74.94%

―

Hightide Therapeutics Inc

HK$3.05

HK$1.74B

-2.75

24.36%

1 Buy

0 Hold

0 Sell

Moderate Buy

xxxxxxxxxxxxx

2185 vs 2511

xxxxxxxxxxxxx

Performance Comparison

HK:2185

Shanghai Bio-Heart Biological Technology Co., Ltd. Class H

3.69

1.13

44.14%

HK:6998

Genor Biopharma Holdings Limited

2.11

-0.57

-21.27%

HK:1875

TOT BIOPHARM International Co. Ltd.

4.46

2.66

147.78%

HK:6622

Zhaoke Ophthalmology Ltd.

2.53

0.30

13.45%

HK:6978

Immunotech Biopharm Ltd

0.79

-2.33

-74.68%

HK:2511

Hightide Therapeutics Inc

3.42

0.80

30.53%

Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts

Compare More Stocks >